COMT inhibition in the treatment of Parkinson's disease: Neuroprotection and future perspectives

被引：0
|
作者：
Kostic, VS [1 ]
机构：
[1] Inst Neurol CCS, YU-11000 Belgrade, Serbia
来源：
FRONTIERS IN CLINICAL NEUROSCIENCE: NEURODEGENERATION AND NEUROPROTECTION: A SYMPOSIUM IN ABEL LAJTHA'S HONOUR | 2004年 / 541卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：75 / 90
页数：16
相关论文
共 50 条
  • [31] Neuroprotection and Disease Modification in Parkinson's Disease
    Otero-Losada, Matilde
    Gubellini, Paolo
    Capani, Francisco
    Perez-Lloret, Santiago
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [32] The Main Targets Involved in Neuroprotection for the Treatment of Alzheimer's Disease and Parkinson Disease
    Gulcan, Hayrettin O.
    Orhan, Ilkay E.
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (04) : 509 - 516
  • [33] The Impact of COMT-inhibition on Gastrointestinal Levodopa Absorption in Patients with Parkinson's Disease
    Mueller, Thomas
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 155 - 168
  • [34] Progress in neuroprotection in Parkinson's disease
    Schapira, A. H. V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 5 - 13
  • [35] Neuroprotection in Parkinson's disease; a commentary
    Mabel Gatto, Emilia
    Riobo, Natalia
    Cecilia Carreras, Maria
    Jose Poderoso, Juan
    Micheli, Federico E.
    NEUROTOXICITY RESEARCH, 2002, 4 (02) : 141 - 145
  • [36] COMT Inhibitors in the Management of Parkinson’s Disease
    Margherita Fabbri
    Joaquim J. Ferreira
    Olivier Rascol
    CNS Drugs, 2022, 36 : 261 - 282
  • [37] The conundrum of neuroprotection in Parkinson's disease
    Antonini, Angelo
    LANCET NEUROLOGY, 2011, 10 (05): : 396 - 397
  • [38] Neuroprotection in Parkinson’s disease; a commentary
    Emilia Mabel Gatto
    Natalia Riobó
    María Cecilia Carreras
    Juan José Poderoso
    Federico E. Micheli
    Neurotoxicity Research, 2002, 4 : 141 - 145
  • [39] Targets for neuroprotection in Parkinson's disease
    Yacoubian, Talene A.
    Standaert, David G.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (07): : 676 - 687
  • [40] Prospects for neuroprotection in Parkinson's disease
    Olanow, CW
    NEUROLOGY, 2006, 66 (10) : S1 - S1
12345